Published in Invest Ophthalmol Vis Sci on August 01, 2005
Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease. J Ocul Pharmacol Ther (2012) 0.97
Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants. Invest Ophthalmol Vis Sci (2015) 0.77
Ocular manifestations of graft-versus-host disease. Saudi J Ophthalmol (2013) 0.77
Effects of mycophenolate mofetil on proliferation and mucin-5AC expression in human conjunctival goblet cells in vitro. Mol Vis (2010) 0.77
Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model. Biol Blood Marrow Transplant (2016) 0.75
Dry Eye Management: Targeting the Ocular Surface Microenvironment. Int J Mol Sci (2017) 0.75
Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med (2002) 3.94
A biomarker panel for acute graft-versus-host disease. Blood (2008) 3.83
Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol (2009) 3.67
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med (2013) 3.27
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A (2012) 3.21
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res (2011) 3.18
Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study. Ophthalmology (2011) 2.86
A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection. Psychother Psychosom (2013) 2.74
Adverse functions of IL-17A in experimental sepsis. FASEB J (2008) 2.60
Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis (2002) 2.53
Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc Natl Acad Sci U S A (2004) 2.41
Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol Cell (2012) 2.34
Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet (2005) 2.32
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab. Cancer Res (2013) 2.27
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest (2008) 2.23
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood (2008) 2.21
Elafin is a biomarker of graft-versus-host disease of the skin. Sci Transl Med (2010) 2.08
Keratoplasty for corneal endothelial disease, 2001-2009. Ophthalmology (2012) 2.03
Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res (2010) 1.96
Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol (2004) 1.91
A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med (2005) 1.88
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant (2006) 1.87
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. Blood (2012) 1.85
Immunobiology of acute graft-versus-host disease. Blood Rev (2003) 1.83
Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality. Blood (2013) 1.82
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease. Blood (2007) 1.79
Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant (2003) 1.75
Keratomalacia caused by psychiatric-induced dietary restrictions. Cornea (2007) 1.62
Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med (2011) 1.61
Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol Cell Proteomics (2005) 1.59
Critical role of host gammadelta T cells in experimental acute graft-versus-host disease. Blood (2005) 1.58
Rapid, noninvasive detection of diabetes-induced retinal metabolic stress. Arch Ophthalmol (2008) 1.57
Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells. J Immunol (2005) 1.53
The effect of orbital decompression surgery on lid retraction in thyroid eye disease. Ophthal Plast Reconstr Surg (2011) 1.51
Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol (2003) 1.46
Group A streptococcal necrotizing fasciitis of the eyelids and face managed with debridement and adjunctive intravenous immunoglobulin. Ophthal Plast Reconstr Surg (2009) 1.46
Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp Eye Res (2007) 1.45
Silicone spacer repair of medial rectus after iatrogenic orbit fracture. Ophthal Plast Reconstr Surg (2012) 1.38
MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet (2012) 1.38
The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res (2002) 1.37
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biol Blood Marrow Transplant (2010) 1.36
Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood (2012) 1.35
Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol Vis (2006) 1.34
Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood (2003) 1.30
Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia (2012) 1.25
Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat (2005) 1.23
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease. Biol Blood Marrow Transplant (2005) 1.21
Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res (2007) 1.20
Tarsal dermoid cyst: clinical presentation and treatment. Ophthal Plast Reconstr Surg (2009) 1.18
Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukoc Biol (2003) 1.16
Acute graft-versus-host disease: new treatment strategies. Curr Opin Hematol (2009) 1.16
A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. J Immunol (2010) 1.14
Toll-like receptor 4 (TLR4) of retinal pigment epithelial cells participates in transmembrane signaling in response to photoreceptor outer segments. J Gen Physiol (2004) 1.14
Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation. Blood (2002) 1.14
Effector T cells require fatty acid metabolism during murine graft-versus-host disease. Blood (2013) 1.13
Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. Blood (2004) 1.11
Rupture of anterior lens capsule from blunt ocular injury. J Cataract Refract Surg (2009) 1.11
Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood (2003) 1.11
Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am (2010) 1.10
Plasma CXCL9 elevations correlate with chronic GVHD diagnosis. Blood (2013) 1.08
The meaning of diagnoses in orbital disease. Ophthal Plast Reconstr Surg (2013) 1.08
Ultrasonic bone removal versus high-speed burring for lateral orbital decompression: comparison of surgical outcomes for the treatment of thyroid eye disease. Ophthal Plast Reconstr Surg (2010) 1.08
Advances in predicting acute GVHD. Br J Haematol (2012) 1.07
Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression. Invest Ophthalmol Vis Sci (2004) 1.07
Dual involvement of caspase-4 in inflammatory and ER stress-induced apoptotic responses in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2009) 1.07
Glaucoma associated with Boston type I keratoprosthesis. Cornea (2012) 1.05
Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest (2002) 1.04
A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood (2003) 1.03
Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2002) 1.03
Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol (2002) 1.01
Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood (2002) 0.98
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma. J Clin Oncol (2002) 0.98
Clinicopathologic correlation and genetic analysis in a case of posterior polymorphous corneal dystrophy. Am J Ophthalmol (2003) 0.96
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT). Biol Blood Marrow Transplant (2008) 0.96
Double silicone tube intubation for the management of partial lacrimal system obstruction. Ophthalmology (2008) 0.94
Intravitreal daptomycin: a safety and efficacy study. Retina (2011) 0.94
Periocular versus general anesthesia for ocular enucleation. Ophthal Plast Reconstr Surg (2008) 0.94
Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation. Immunol Rev (2012) 0.94
Corneal graft rejection 10 years after penetrating keratoplasty in the cornea donor study. Cornea (2014) 0.94
Role of interleukin-18 in acute graft-vs-host disease. J Lab Clin Med (2003) 0.93
Human RPE-monocyte co-culture induces chemokine gene expression through activation of MAPK and NIK cascade. Exp Eye Res (2003) 0.92
Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation. Cancer Res (2002) 0.92
Plasma biomarkers in graft-versus-host disease: a new era? Biol Blood Marrow Transplant (2009) 0.91
Rare incorporation of bone marrow-derived cells into kidney after folic acid-induced injury. Stem Cells (2005) 0.91
Activation of P2X receptors induces apoptosis in human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2011) 0.91